OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
1134$0.3456

Kelfred Holdings Ltd

Medical Equipment, Supplies & DistributionVerified

Kelfred Holdings Ltd operates with a market capitalization of HKD 170 million and a price-to-book ratio of 1.14, indicating a valuation slightly above tangible book value. The company's liquidity position is characterized by a current ratio of 1.91, suggesting it can cover short-term obligations with a moderate buffer. However, the negative net cash position after subtracting total debt raises concerns about short-term liquidity. Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of HKD 15.1 million and an operating loss of HKD 11.1 million, resulting in a negative return on equity of -10.18% and a negative return on assets of -5.35%. These figures indicate a failure to generate returns for shareholders or utilize assets efficiently. The company's revenue is concentrated in a single business segment focused on eyewear products, with no disclosed geographic diversification. This lack of segment or geographic diversification increases exposure to sector-specific risks and regional economic fluctuations. Looking ahead, the company's revenue outlook is uncertain, with no disclosed growth trajectory or specific numeric deltas for the current or next fiscal year. Historical revenue of HKD 500.3 million masks the underlying profitability challenges, as gross profit of HKD 59.3 million was insufficient to offset operating expenses. The risk assessment highlights medium liquidity risk and low dilution potential. The negative net cash position after subtracting total debt is a key flag, suggesting potential pressure to secure additional financing. No dilution adjustments were applied in the valuation, and no recent equity issuance activity was disclosed. Recent filings and transcripts do not provide additional insight into strategic initiatives or operational changes. The company's 10-K Risk Factors section and other disclosures do not mention specific near-term dilution sources or material events that would alter the current risk profile.

30-day price · 1134+0.04 (+15.0%)
Low$0.27High$0.39Close$0.34As of22 May, 00:00 UTC
Profile
CompanyKelfred Holdings Ltd
Ticker1134.HK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Kelfred Holdings Ltd is an investment holding company engaged in the design, production, and sale of eyewear products, primarily optical frames and sunglasses, through ODM and OEM business models.

Classification. Kelfred Holdings Ltd is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Kelfred Holdings Ltd operates with a market capitalization of HKD 170 million and a price-to-book ratio of 1.14, indicating a valuation slightly above tangible book value. The company's liquidity position is characterized by a current ratio of 1.91, suggesting it can cover short-term obligations with a moderate buffer. However, the negative net cash position after subtracting total debt raises concerns about short-term liquidity. Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of HKD 15.1 million and an operating loss of HKD 11.1 million, resulting in a negative return on equity of -10.18% and a negative return on assets of -5.35%. These figures indicate a failure to generate returns for shareholders or utilize assets efficiently. The company's revenue is concentrated in a single business segment focused on eyewear products, with no disclosed geographic diversification. This lack of segment or geographic diversification increases exposure to sector-specific risks and regional economic fluctuations. Looking ahead, the company's revenue outlook is uncertain, with no disclosed growth trajectory or specific numeric deltas for the current or next fiscal year. Historical revenue of HKD 500.3 million masks the underlying profitability challenges, as gross profit of HKD 59.3 million was insufficient to offset operating expenses. The risk assessment highlights medium liquidity risk and low dilution potential. The negative net cash position after subtracting total debt is a key flag, suggesting potential pressure to secure additional financing. No dilution adjustments were applied in the valuation, and no recent equity issuance activity was disclosed. Recent filings and transcripts do not provide additional insight into strategic initiatives or operational changes. The company's 10-K Risk Factors section and other disclosures do not mention specific near-term dilution sources or material events that would alter the current risk profile.
Key takeaways
  • Kelfred Holdings Ltd is operating at a loss with negative returns on equity and assets.
  • The company's liquidity position is moderate, but its negative net cash position raises concerns.
  • Revenue is concentrated in a single business segment with no geographic diversification.
  • No clear growth trajectory or revenue outlook is disclosed for the current or next fiscal year.
  • The risk profile is characterized by medium liquidity risk and low dilution potential.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyHKD
Revenue$500.3M
Gross profit$59.3M
Operating income-$11.1M
Net income-$15.1M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$282.8M
Total liabilities$134.3M
Total equity$148.5M
Cash & equivalents
Long-term debt$8.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.34
Market cap$170.0M
Enterprise value$178.5M
P/E
Reported non-GAAP P/E
EV/Revenue0.4
EV/Op income
EV/OCF
P/B1.1
P/Tangible book1.1
Tangible book$148.5M
Net cash-$8.5M
Current ratio1.9
Debt/Equity0.1
ROA-5.3%
ROE-10.2%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric1134Activity
Op margin-2.2%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-3.0%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin11.9%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue3.0% medp25 2.7% · p75 4.5%
Debt / equity6.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 07:34 UTC#4e57d921
Market quoteclose HKD 0.34 · shares 0.50B diluted
no public URL
2026-05-04 07:34 UTC#47c4e0a2
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 07:35 UTCJob: ecfb9674